Cited by 226Alzheimer's disease research and treatmentsNuclear Structure and FunctionAmyotrophic Lateral Sclerosis Research

Lamin Dysfunction Mediates Neurodegeneration in Tauopathies

Open access
Frost, Bess, Bardai, Farah H., Feany, Mel B.·2016·Current Biology

Abstract

The filamentous meshwork formed by the lamin nucleoskeleton provides a scaffold for the anchoring of highly condensed heterochromatic DNA to the nuclear envelope, thereby establishing the three-dimensional architecture of the genome [1]. Insight into the importance of lamins to cellular viability can be gleaned from laminopathies, severe disorders caused by mutations in genes encoding lamins. A cellular consequence of lamin dysfunction in laminopathies is relaxation of heterochromatic DNA [1]. Similarly, we have recently reported the widespread relaxation of heterochromatin in tauopathies [1]: age-related progressive neurodegenerative disorders, including Alzheimer's disease, that are pathologically characterized by aggregates of phosphorylated tau protein in the brain [2, 3]. Here we demonstrate that acquired lamin misregulation though aberrant cytoskeletal-nucleoskeletal coupling promotes relaxation of heterochromatin and neuronal death in an in vivo model of neurodegenerative tauopathy. Genetic manipulation of lamin function significantly modifies neurodegeneration in vivo, demonstrating that lamin pathology plays a causal role in tau-mediated neurotoxicity. We show that lamin dysfunction is conserved in human tauopathy, as super-resolution microscopy reveals a significantly disrupted nuclear lamina in postmortem tissue from human Alzheimer's disease brain. Our study provides strong evidence that tauopathies are neurodegenerative laminopathies and identifies a new pathway mediating neuronal death in currently untreatable human neurodegenerative disorders, including Alzheimer's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cub.2015.11.039

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Expression of human wild-type or R406W mutant tau involves the same major mechanisms of tau-induced neurotoxicity in Drosophila models.

    “Multiple previous studies report that expression of human wild-type or R406W mutant tau involve the same major mechanisms of tau-induced neurotoxicity in Drosophila models10,16,20.”

    From Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies (2018) · cites this paper as [16]

    The Results (page not provided) show that both wild-type and R406W tau reduce Lamin levels and cause Lamin invagination in Drosophila, supporting a shared pathway of toxicity. The paper does not establish that the two forms involve the same major mechanisms overall; its subsequent mechanistic experiments use R406W tau. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • The paper observed DSB-mediated changes in the levels of nuclear structural proteins, cohesin, and Lamin B1, in neurons enriched for DSBs.

    “We also observed DSB-mediated changes in the levels of nuclear structural proteins, cohesin, and Lamin B1, in neurons enriched for DSBs, similar to previous observations in AD neurons and also in senescent astrocytes133,134.”
  • AD has been explicitly referred to as an acquired neurodegenerative laminopathy, and lamin dysfunction has been shown to drive tau-mediated neurodegeneration.

    “Indeed, AD has been explicitly referred to as an acquired neurodegenerative laminopathy [41], and lamin dysfunction has been shown to drive tau-mediated neurodegeneration [42].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 226

Authors
Frost, B., Bardai, F. H., & Feany, M. B.
Affiliations
Brigham and Women's Hospital (US)
Venue
Current Biology
Publisher
Elsevier BV
Published
2016-01
Volume
26
Issue
1
Pages
129-136
ISSN
0960-9822 (ISSN-L)
OpenAlex
W2203120038
Cited by
226
References
40
Citations by year
2026: 15 · 2025: 22 · 2024: 27 · 2023: 26 · 2022: 23 · 2021: 26 · 2020: 27 · 2019: 18 · 2018: 19 · 2017: 14 · 2016: 9
FWCI
10.31
Type
journal article
Language
en
Open access
Locations
  • Current Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute on Aging (R01AG044113, R01AG033518, F32AG039193)
  • National Cancer Institute (P01CA095616)
  • National Institute of General Medical Sciences (R01GM084947)
  • National Institute of Neurological Disorders and Stroke (R00NS088429, U24NS050606, K99NS088429)
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
Keywords
laminopathies, tauopathy, Alzheimer's disease, neurodegeneration, nuclear lamina, neuronal cell death, tau phosphorylation, nuclear organization
MeSH terms
Alzheimer Disease, Animals, Brain, Cytoskeleton, Drosophila, Heterochromatin, Humans, Mutation, Nuclear Envelope, tau Proteins, Tauopathies, Animals, Genetically Modified, Lamins, Lamin Type A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review